P
MDT icon

&Partners’s Medtronic MDT Stock Holding History

&Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.5M Buy
468,613
+19,526
+4% +$1.87M 0.2% 103
2025
Q4 		$43.2M Buy
449,087
+52,081
+13% +$5.06M 0.23% 90
2025
Q3 		$37.8M Buy
397,006
+35,907
+10% +$3.3M 0.24% 91
2025
Q2 		$31.5M Buy
361,099
+34,150
+10% +$2.9M 0.24% 93
2025
Q1 		$28.7M Buy
326,949
+66,302
+25% +$5.93M 0.3% 70
2024
Q4 		$21.1M Buy
260,647
+105,501
+68% +$9.13M 0.25% 85
2024
Q3 		$14M Buy
155,146
+104,495
+206% +$8.79M 0.27% 85
2024
Q2 		$3.99M Buy
50,651
+39,808
+367% +$3.26M 0.17% 131
2024
Q1 		$951K Buy
10,843
+7,591
+233% +$648K 0.13% 160
2023
Q4 		$256K Buy
+3,252
New +$248K 0.06% 236
2023
Q1 		– Sell
-3,047
Closed -$237K – 187
2022
Q4 		$237K Sell
3,047
-246
-7% -$19.9K 0.12% 150
2022
Q3 		$266K Buy
3,293
+259
+9% +$23.3K 0.15% 132
2022
Q2 		$272K Buy
3,034
+751
+33% +$76.1K 0.16% 130
2022
Q1 		$253K Buy
2,283
+86
+4% +$9.09K 0.14% 149
2021
Q4 		$227K Sell
2,197
-239
-10% -$27.7K 0.14% 158
2021
Q3 		$305K Buy
2,436
+100
+4% +$12.9K 0.19% 118
2021
Q2 		$290K Buy
+2,336
New +$293K 0.19% 124

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

&Partners's MDT Position: Q1 2026 in Review

&Partners increased its Medtronic (MDT) stake by 4.3% in Q1 2026, buying an estimated $1.87M and bringing the position to 468,613 shares worth $40.5M. The position accounts for 0.2% of the portfolio, ranked #103.

&Partners first reported a position in MDT in Q2 2021 and has held it in 17 quarters since. The position peaked at $43.2M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • &Partners held 468,613 shares of Medtronic worth $40.5M as of Q1 2026.
  • &Partners bought 19,526 Medtronic shares in Q1 2026, an estimated $1.87M.
  • Medtronic made up 0.2% of &Partners's portfolio in Q1 2026, its #103 holding.
  • &Partners first reported a position in Medtronic in Q2 2021 and has held it in 17 quarters since.
  • &Partners's Medtronic position peaked at $43.2M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.